Neurofeedback Training for Aging
(DecidingBrain Trial)
Trial Summary
What is the purpose of this trial?
Much of human interaction is based on trust. Aging has been associated with deficits in trust-related decision making, likely further exacerbated in age-associated neurodegenerative disease (Alzheimer's disease/AD), possibly underlying the dramatically growing public health problem of elder fraud. Optimal trust-related decision making and avoiding exploitation require the ability to learn about the trustworthiness of social partners across multiple interactions, but the role that learning plays in determining age deficits in trust decisions is currently unknown. Aim: Probe the malleability of the underlying neurocircuitry of trust-learning deficits in aging. This study will utilize real-time fMRI neurofeedback to train older adults in brain activity up-regulation toward enhanced trust-related learning in aging and confirm critical mechanisms of experience-dependent social decisions in aging. Grant R01AG072658 Aim 3: Test the malleability of trust-learning neurocircuitry toward optimized trust-related decision making in aging.
Will I have to stop taking my current medications?
The trial requires that you are on a stable medication regimen, so you won't need to stop your current medications unless they are anticholinergics, anticonvulsants, neuroleptics, sedatives, or other drugs known to affect cognition.
What data supports the effectiveness of the treatment rtfMRI-guided Neurofeedback Training for aging?
Is neurofeedback training using real-time fMRI safe for humans?
Real-time fMRI neurofeedback has been used in various studies and is generally considered safe for humans, with no extensive reports of adverse events. It has been applied in research for conditions like schizophrenia and nicotine addiction, showing behavioral benefits without significant safety concerns.16789
How is rtfMRI-guided Neurofeedback Training different from other treatments for cognitive decline in aging?
rtfMRI-guided Neurofeedback Training is unique because it uses real-time brain imaging to help individuals learn to control their brain activity, potentially improving cognitive functions like attention and memory. Unlike traditional cognitive training, this method provides immediate feedback on brain activity, allowing for more targeted and personalized interventions.12359
Research Team
Natalie C. Ebner, PhD.
Principal Investigator
University of Florida
Eligibility Criteria
This trial is for individuals aged 60-85 who can consent, speak English fluently, have at least an 8th-grade education level, and are on a stable medication regimen. It's focused on those experiencing mild cognitive impairments or changes in trust-related decision making as they age.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-training
Participants undergo pre-training MRI scans to establish baseline brain activity
Training
Participants receive rtfMRI neurofeedback training to enhance trust-related learning
Post-training
Participants undergo post-training MRI scans to assess changes in brain activity
Follow-up
Participants are monitored for changes in trust-related learning and decision making
Treatment Details
Interventions
- rtfMRI-guided Neurofeedback Training (Behavioral Intervention)
- Sham Control (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
National Institute on Aging (NIA)
Collaborator